Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lichter DA"'
Autor:
von Euw Erika, Atefi Mohammad, Attar Narsis, Chu Connie, Zachariah Sybil, Burgess Barry L, Mok Stephen, Ng Charles, Wong Deborah JL, Chmielowski Bartosz, Lichter David I, Koya Richard C, McCannel Tara A, Izmailova Elena, Ribas Antoni
Publikováno v:
Molecular Cancer, Vol 11, Iss 1, p 22 (2012)
Abstract Background TAK733 is a novel allosteric, non-ATP-binding, inhibitor of the BRAF substrates MEK-1/2. Methods The growth inhibitory effects of TAK733 were assessed in a panel of 27 cutaneous and five uveal melanoma cell lines genotyped for dri
Externí odkaz:
https://doaj.org/article/ce5029448ceb46ae8246771e3b3ee94f
Autor:
Lichter DA
Publikováno v:
Health progress (Saint Louis, Mo.) [Health Prog] 2014 Sep-Oct; Vol. 95 (5), pp. 57-9.
Autor:
Lichter DA; National Association of Catholic Chaplains, Milwaukee, USA.
Publikováno v:
Health progress (Saint Louis, Mo.) [Health Prog] 2013 Mar-Apr; Vol. 94 (2), pp. 62-6.
Autor:
Lichter DA; National Association of Catholic Chaplains, Milwaukee, USA., O'Gorman ML
Publikováno v:
Health progress (Saint Louis, Mo.) [Health Prog] 2009 May-Jun; Vol. 90 (3), pp. 30-3.